Introduction
In cardiac tissue there are three main cell types: cardiomyocytes, vascular cells, and fibroblasts. Fibroblasts represent around 30% of the total heart cell population (1) . Fibroblasts are flat spindle-shaped cells of mesenchymal origin responsible for extracellular matrix homeostasis (2, 3) . Fibroblasts do not possess a definitive cell marker, so their characterization relies on morphological, proliferative, and phenotypical characteristics (2) . Although, a protein that is expressed exclusively in fibroblasts is not described, in human and mouse cardiac tissue, fibroblasts can be identified by the expression of collagen-activated receptor tyrosine kinase discoidin domain receptor 2 (DDR2) and intermediatefilament associated calcium-binding protein S100A4 (or fibroblast-specific protein 1 [FSP-1]) (1, 4) . Cardiac fibroblasts play various roles among which electrical coupling, paracrine signaling and tissue repair after injury are the most described (5) .
In a normal situation, cardiac fibroblasts have low secretory activity and produce extracellular matrix proteins, such as collagen types I and III, laminin and fibronectin. They also synthesize and secrete various metalloproteinases that are responsible for extracellular matrix degradation, and several growth factors and cytokines (6) . However, upon tissue injury, cardiac fibroblasts differentiate to cardiac myofibroblasts.
Myofibroblasts are characterized by an augmented capacity to synthesize and secrete collagen and other extracellular matrix proteins important for scar formation and wound healing (5) . They have lower migratory and proliferative capacity than cardiac fibroblasts (7) but with an increased resistance to apoptosis (8) . Furthermore, from a structural point of view, myofibroblasts have a specialized contractile protein, α-smooth muscle actin (α-SMA), commonly used as a marker for differentiation (9, 10) . Due to the reduced susceptibility to apoptosis, myofibroblasts remain in the myocardial tissue, causing excessive secretion and deposition of extracellular matrix components, increasing myocardial tissue stiffness (4, 11) , which can contribute to the progressive cardiac pathological remodeling (12, 13) . Furthermore, the fibrotic scar can cause disruption of electrical signaling and muscle contraction which eventually result in heart failure (5). Participation of myofibroblasts in pathological fibrosis is not limited to the heart (14), but is a common hallmark of all fibrotic processes, including lung (15) and liver (16) among others. Therefore, the control of fibroblast to myofibroblast differentiation is an interesting target in order to prevent adverse consequences of tissue fibrosis and remodeling.
TGF-β
Transforming growth factor-β (TGF-β) are cytokines belonging to a peptide family with multiple physiological and pleiotropic functions, including inflammatory and immune responses, cell proliferation, growth, differentiation and collagen production (17) (18) (19) (20) . In mammals, three isoform (TGF-β1, TGF-β2, TGF-β3) have been described, each isoform encoded by different genes (21) . TGF-β1 is expressed in a broad range of cells including fibroblasts, T-cells, B-cells, macrophages, and epithelial and endothelial cells and almost all of them have specific receptors for this peptide (22) (23) (24) . TGF-β1, TGF-β2 and TGF-β3 are released in a nonactive latent form (L-TGF-β) that binds to the L-TGF-β binding protein 1 (LTBP1) in the extracellular matrix. In order to be activated L-TGF-β is proteolyzed by thrombospondin-1 or plasmin (25) . TGF-β1, TGF-β2, and TGF-β3 all function through the same receptor signaling system (22) . TGF-β1 receptors (TβR) are single transmembrane serine/threonine kinase receptors (17) . TGF-β1 binding to type II receptor (TβRII) homodimer induces the recruitment of a receptor type I (TβRI) homodimer resulting in a heterotetramer complex. The TβRII serine/threonine kinase catalyzes unidirectional phosphorylation of TβRI, which activates the receptor (26, 27) .
Subsequently, Smad-dependent and Smad independent signaling pathways are activated ( Figure  1 ). The Smad-dependent signaling pathway is the canonical transductional pathway for TGF-β. Activated TβRI phosphorylates Smad 2/3 at the SSXS C-terminal motif. Later, Smad2/3 dissociates from the receptor to induce the myofibroblast phenotype, but it exerts a permissive effect on TGF-β activity (43).
FoxO transcription factors
A recent study in cardiac fibroblasts, Vivar et al. demonstrated that TGF-β1 induces differentiation of fibroblast into myofibroblast in a FoxO1 dependent manner (34) . The forkhead transcription factor superfamily is characterized by a winged-helix DNA binding motif and the forkhead domain (45) . The mammalian forkhead transcription factors of the O class (FoxO) have four members: FoxO1, FoxO3, FoxO4, and FoxO6. FoxO1 and FoxO3 are expressed in most tissues and cells, including fibroblasts (46) . FoxO4 is highly expressed in muscle, kidney, and colorectal tissue while FoxO6 has been seen only in the central nervous system (47) . FoxOs recognize two response elements and binds to the insulin-responsive element (5'-(C/A)(A/C)AAA(C/T)AA-3') with higher affinity than to the Daf-16 family member binding element (5'-GTAAA(T/C)AA-3') (48).
Hosaka et al. developed KO mice for FoxO1, FoxO3 and FoxO4 (49) . FoxO1 KO is lethal in embryonic stages due to lack of vascular development. FoxO3 and FoxO4 KO mice are viable and show normal growth in appearance, but have altered lymph proliferation, widespread organ inflammation (50) and decline in the neural stem cell pool (51) , as compared to wild type mice. FoxO3 KO female mice showed irregular ovarian follicle growth causing infertility (49) . FoxO4 KO exacerbates colitis in response to inflammatory stimuli (52) . FoxO6 KO mice display normal learning but impaired memory consolidation (53) .
FoxO transcriptional activity is regulated by different post-translational modifications, mainly through phosphorylation, acetylation and ubiquitination (54, 55) . These modifications can activate or inactivate the function as a transcription factor. They alter its subcellular localization, modify the DNA binding affinity, and change the pattern of transcriptional activity for specific target. The main pathway regulating FoxO activity is the phosphorylation by Akt in three different sites (T24, S256 and S319), which favors their interaction with 14-3-3 adapter protein inhibiting its interaction with DNA and promoting their nuclear export and subsequent degradation by proteasome (55, 56) . Also, deacetylase protein sirtuin, such as SIRT1, can deacetylate FoxO, preventing its phosphorylation by Akt, leading to its activation (57) .
Additionally to Akt, there are other kinases that can phosphorylate FoxO. ERK (58) , IkB kinase (IKK) (59) and casein kinase 1 (CK1) (60) negatively regulate FoxO activity by inducing active exportation of the nucleus to the cytosol. On the other hand, under general stress conditions, other kinases can promote FoxO nuclear import. Oxidative stress induces FoxO and binds to a coSmad, e.g. Smad 4. This complex translocates to the nucleus and acts as a transcription factor controlling the expression of several genes (28) . In the Smad-independent pathway many signaling cascades are described. TGF-β rapidly activates Rho family guanosine triphophatases (GTPases) (29) . TGF-β dependent activation of RhoA pathway induces the translocation of myocardin related transcription factor A (MRTF-A) to the nucleus to regulate a profibrotic response (30, 31) . TGF-β activates mitogen-activated protein kinases, including (extracellular signal-regulated kinases) ERKs, p38, and c-Jun N-terminal kinases (JNKs) through their upstream kinase activators such as transforming growth factor-β activated kinase-1 (TAK1) (29) . In human lung fibroblasts, TGF-β induction of endothelin-1 occurs via activation of JNK, and endothelin-1 acts via the endothelin-A/B receptors to initiate Rac/Akt/Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) signaling, resulting in expression of α-SMA. TGF-β1 can also activate the PI3K pathway which in turn induces Akt by selective phosphorylation at S473, but not at T308. Akt, in turn, phosphorylates and inhibits FoxO transcription factors, associated with the prevention of regulatory T cell differentiation (32).
TGF-β and fibroblasts
TGF-β1 plays an important role in fibrosis, because it mediates the differentiation of fibroblast into myofibroblast (7, 33) . Several line of evidences support the importance of TGF-β in the induction and maintenance of the fibrotic response. In cultured fibroblasts, TGF-β directly induces collagen production and contraction by fibroblasts, including those isolated from heart tissue (34) . Subcutaneous injection of TGF-β results in enhanced deposition of extracellular matrix (35) . Treatment of wounds with TGF-β promotes wound closure and scarring (36) . Moreover, blocking TGF-β with antibodies (37) or anti-sense oligonucleotides (38) reduces collagen deposition and scarring. Overexpression of TGF-β in heart induces myocardial fibrosis (39), while blunting TGF-β1 expression, using TGF-β knock out (KO) mice or dominant negative TGF-β receptor mice, markedly reduced collagen deposition (40) .
Besides TGF-β1, fibroblast to myofibroblast differentiation also requires mechanical tension, which is regulated by the interaction between the contractile activity of myofibroblasts and the stiffness of the extracellular matrix (41, 42) . Inhibition of mechanical stress triggers α-SMA protein level decrease (42), a widely used marker of myofibroblast differentiation. Also, during wound healing, fibroblasts express the ED-A fibronectin, which is crucial for fibroblast to myofibroblast differentiation and for a normal scar formation (43, 44) . Furthermore, it is demonstrated that ED-A fibronectin is necessary, but not sufficient, phosphorylation by JNK and Mammalian Ste20-like kinase (MST1), and activates the expression of antioxidant genes such as superoxide dismutase. Also, by nutrient stress, AMP-activated protein kinase (AMPK) phosphorylates FoxO, and induce energy metabolism related gene expression (45).
FoxO and fibroblasts
Several articles have described the role of FoxO in fibroblast physiology. There are only few articles describing role of FoxO in cardiac fibroblast. In order to obtain a more wide perspective of FoxO actions, fibroblast from other sources were included in this review. Therefore, here we summarize the available information and highlight its relevance for fibroblast to myofibroblast differentiation.
FoxO1
In a model of iron-overload cardiomyopathy, cardiac fibrosis was observed associated with an increase of α-SMA levels. These data suggest that iron overload induces cardiac fibroblast to myofibroblast differentiation. Interestingly, in these cells an increase in FoxO1 nuclear localization was observed (61) . In neonatal cardiac fibroblast TGF-β1 induces fibroblast to myofibroblast differentiation, which is completely prevented by FoxO1 inhibition (34) . In this cell model, TGF-β1 increases in a time and dose dependent manner FoxO1 mRNA and protein levels, induces FoxO1 dephosphorylation, increases FoxO1 nuclear translocation and increases FoxO1 target gene transcription (34) . Moreover, FoxO1 overexpression enhances TGF-β1 effects on cardiac fibroblasts (34) . Taken together, these data suggest that FoxO1 is required for TGF-β1 dependent fibroblast to myofibroblast differentiation. Remains to be elucidated whether the participation of FoxO1 is exclusively associated to TGF-β1 or is a general mediator of fibroblast to myofibroblast differentiation.
One of the main skin alteration that take place during wound healing remodeling is the elimination of fibroblasts by apoptosis (62, 63) . FoxO transcription factors play a key role in the regulation of this process (64) . In primary human dermal fibroblasts, TNFα activates FoxO1 expression, decreasing fibroblast proliferation (64, 65) . Silencing of FoxO1 using a siRNA, reduced TNFα induced fibroblast apoptosis as well as a wide range of TNFα-induced pro-apoptotic genes (64) . Both results suggest that the ability of TNFα to induce dermal fibroblast apoptosis and to inhibit their proliferation requires FoxO1 activation. Skin damage by arsenic acid activates FoxO1 through a mechanism involving MST1 activation by a reactive oxygen species (ROS) dependent mechanism. Consequently, FoxOs translocate to nucleus and inhibit cell proliferation of mouse skin fibroblasts (66) . In human foreskin fibroblasts, growth factors such as PDGF, FGF and IGF-I can inhibit the expression of FoxO genes, promoting their proliferation (67) . PDGF promoted FoxO1 phosphorylation and translocation from the nucleus to the cytosol, and FoxO1 inhibition using a shRNA, led to fibroblast proliferation (67) . FoxO1 inhibition of human foreskin fibroblast proliferation is partially due to an increase in high-mobility group-box protein 1 expression (68) . Additionally, in primary human adult dermal fibroblasts, dehydroabietic acid can reverse TNFα stimulated cell responses, including FoxO1 activation, and increase fibroblast proliferation (65) . Interestingly, in excisional wounds from mice with type 1 or type 2 diabetes, increased levels of apoptosis, TNFα and FoxO1 activation was observed in fibroblasts (69, 70) . In diabetic db/db mice, FoxO1 regulates cell cycle genes in a TNFα-independent manner, and FoxO1 inhibition using a siRNA, blocked the TNFα-induced pro-inflammatory genes (70) . Therefore, in patients with diabetes, FoxO1 could be an important target for the treatment of diabetic foot and other skin complications. Taken together, these results suggest that FoxO1 is an important regulator of wound healing, through the control of fibroblast apoptosis and proliferation. However, in none of these works a relationship between proliferation and apoptosis with fibroblast to myofibroblast differentiation was studied.
Prostaglandin E2 (PGE2) signaling is an important inhibitor of primary fetal and adult lung fibroblast to myofibroblast differentiation, by counteracting the effects of TGF β1 (71) . Additionally, PGE2 can also reverse the established myofibroblast differentiation (72) . On the other hand, PGE2 promotes FoxO1 phosphorylation and nuclear export by PI3K/Akt activation (73) . However, whether FoxO1 is involved in the PGE2-induced reversion of myofibroblast differentiation remains unexplored.
In the liver, a relationship between FoxO1 and the differentiation of hepatic stellate cells to myofibroblasts has also been found. In a model of mice hepatic fibrosis, FoxO1 inhibition in hepatic stellate cells, assessed by an increase in FoxO1 phosphorylation and its subsequent exclusion of the nucleus, induces an increase in α-SMA levels (74) . This data suggest that in this mice model, FoxO1 inhibits the hepatic stellate cells to myofibroblast differentiation. However, an inversed relationship was observed in humans. Patients with nonalcoholic steatohepatitis had low levels of phosphorylated FoxO1 associated with an increased type 1 collagen levels (75) . These contradictory evidences point out that the role of FoxO1 in the hepatic stellate cells to myofibroblasts differentiation needs to be further analyzed.
FoxO3
In adult rat cardiac fibroblasts, FoxO3a regulates cell cycle progression by increasing p27kip1 expression, an inhibitor of cyclin dependent kinase, through an ERK1/2 dependent signaling pathway (76) . In the heart of diabetic mice elevated collagen levels is associated with low levels of FoxO3 (77) . Additionally, FoxO3 inactivation by resveratrol decreases cardiac fibrosis produced by exercise (78) . However, in this model, exercise-induced fibrosis is not related with FoxO3 phosphorylation (78) . All these data suggest that FoxO3 inactivation is associated with a decreased fibrosis, probably by regulating proliferation and apoptosis sensitivity.
In a model of renal fibrosis induced by unilateral ureteral obstruction, accumulation of collagen and increased expression of α-SMA is associated with FoxO3 inactivation (79) . Moreover, increased FoxO3 expression by silencing microRNA-132, a microRNA that downregulates FoxO3 mRNA, selectively inhibits fibroblast proliferation and decrease renal fibrosis (80) . Primary fibroblast cultures obtained from idiopathic pulmonary fibrosis (IPF) are characterized by their ability to elude the proliferation-suppressive properties of polymerized type I collagen. This ability involves the aberrant activation of the PI3K/Akt signaling pathway that inactivates FoxO3a, resulting in p27kip1 down regulation and a decreased sensitivity to apoptosis (81, 82) . Moreover, in IPF fibroblasts FoxO3a is further inhibited by microRNA-96 (83) . Decreased sensitivity to apoptosis is due to caveolin 1 downregulation which decrease Fas levels (81) . On the other hand, reduced FoxO3 expression is sufficient to generate a hyperproliferative state in IPF fibroblasts (84) . All these findings show that inhibition of FoxO3 is responsible for the maintenance of the proliferative pathological fibroblast phenotype, which contributes to the development of renal or pulmonary fibrosis.
In the liver, FoxO3 also regulates the proliferation and apoptosis of hepatic stellate cells (85, 86) . TRAIL, a member of the TNFα family, induces FoxO3 activation by promoting its nuclear translocation and thereby increasing apoptosis in the LX-2 cell line, an immortalized human hepatic stellate cells (86) . Moreover, FoxO3 activation also promotes an increase in p27kip1 expression, causing a decrease in LX-2 proliferation (85). Therefore, data support the notion that FoxO3 regulates proliferation and apoptosis sensitivity rather than hepatic stellate cell to myofibroblast differentiation.
In primary culture of human dermal fibroblasts, FoxO3a down regulation by siRNA induces a senescent phenotype (87) . In the same way, UV treatment of human dermal fibroblasts also induce the senescent phenotype associated with FoxO3 phosphorylation. Prevention of FoxO3 phosphorylation impedes block senescent phenotype induced by UV treatment (88) . In a model of aging induced by DNA damage in mice embryonic fibroblast (MEF) cells, activation of p53 inhibits FoxO3a transcriptional activity by phosphorylation and subcellular localization change (89) . This phosphorylation could be mediated by serumand glucocorticoid-inducible kinase 1 (SGK1) due to p53-dependent activation of ERK1/2 (89) . These data indicate that FoxO3a regulates senescence and cell cycle progression in fibroblast.
FoxO4
There are only few studies with FoxO4 and fibroblasts. In 3T3L1 fibroblasts, FoxO4 regulates the late steps of cholesterol biosynthesis due to repression of cytochrome P450 sterol 14α-demethylase (CYP51) (90) . The mechanism involves FoxO4 binding to sterol regulatory element-binding protein 2 to upregulate CYP51 and FoxO4 binding to hypoxia-inducible factor-2 to regulate CYP51 repression (91) . Therefore, until now, FoxO4 has only been associated to the regulation of cholesterol metabolism in fibroblast. Figure 2 shows the general actions that are regulated by FoxO transcription factors in fibroblasts. The main action of FoxO1 seems to be the regulation of the fibroblast to myofibroblast differentiation process, especially in cardiac fibroblasts. FoxO1 is regulated by a SMAD independent pathway downstream TGF-β1 receptor. Moreover, FoxO1 has also been involved in the hepatic stellar cell to myofibroblast differentiation in the liver, and possibly in the PGE2-induced reversion of myofibroblast differentiation. In the other hand, FoxO3 shows a close relationship with proliferation, senescence, and apoptosis sensitization in fibroblasts. FoxO3 deregulation is associated with an exacerbated proliferation of fibroblasts leading to renal, pulmonary, skin and cardiac fibrosis. In liver, FoxO3 has also been linked to fibrosis by regulating hepatic stellar cell proliferation. Finally, FoxO4 has only been described as a regulator of cholesterol metabolism. Deciphering the role of FoxO transcription factors could be useful to design effective therapeutic approaches for the treatment of different types of fibrosis.
Conclusions

